Fig 3. Tet markedly decreases phospho-AKT, NF-κB and MMP-9 expression in human RCC.

786-O (A) and 769-P (B) cells treated with vehicle or Tet (0.1μM to 0.5μM) for 24 h were immunoblotted for the expression of AKT, phospho-AKT, NF-κB and MMP-9. β-actin was used as a loading control. The quantitative data were shown in the lower panel (C,D). The values were showed as mean±S.E. Representative results from three independent experiments were shown (** means P<0.05, *** means P<0.01).